Neurocrine Biosciences Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (28)

Latest Posts

About This Stock More About This Stock
3 Breakout Stocks Of The Last Decade To Consider For 2020
Article By: Zacks Investment Research
Tuesday, December 24, 2019 9:30 AM EST
The 2010s were a fruitful decade for investors as the S&P 500 has surged over 189% so far. Here is a look at some stocks that were standouts this past decade and look poised to carry that momentum into 2020.
In this article: AVGO, NBIX, NFLX Also: BA, AAPL, AMZN, FB
Read
4 Biotech Stocks In Neurology, As Biotechs March On
Article By: Tarun Chandra, CFA
Saturday, December 21, 2019 5:20 PM EST
In a space of 2-months, biotechs have gone from recording yearly lows in early October, to recording 2019 highs.
In this article: NBIX, ACAD, KRTX, NERV
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes
Monday, September 9, 2019 7:36 PM EST
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read
Jefferies Says Buy Neurocrine After Yesterday's 'Unwarranted' Selloff
Article By: The Fly
Thursday, November 15, 2018 10:46 AM EST
Jefferies analyst Biren Amin tells investors to buy shares of Neurocrine Biosciences after hosting a dinner with management.
In this article: NBIX
Read
Neurocrine Slides As Ingrezza Serious Cases Count Updated In FDA System
Article By: The Fly
Wednesday, November 14, 2018 5:50 PM EST
In afternoon trading, shares of Neurocrine Biosciences have plunged more than 11% to $88.45.
In this article: NBIX
Read

PARTNER HEADLINES

Latest Tweets for $NBIX

No tweets yet!